Portal de Periódicos da CAPES

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

2017; Springer Science+Business Media; Volume: 11; Issue: 4 Linguagem: Inglês

10.1007/s12072-017-9799-9

1936-0541

Masao Omata, Ann‐Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang–Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana A. Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei‐Jer Chen, Cosmas Rinaldi Adithya Lesmana, Laurentius A. Lesmana, Rino Alvani Gani, Shuntaro Obi, A. Kadir Dökmeci, Shiv Kumar Sarin,

Hepatitis B Virus Studies

There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the "Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines" meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.